Thrombolytic therapy in 1995.
In summary, the amount of research in the field of thrombolysis done in patients with acute myocardial infarction has shown the enormous benefit not only for mortality but other cardiovascular events. Its benefit over other non cardiac conditions are accumulating. Several large-scale studies are underway and expected to give us answers for which conditions will benefit from thrombolytic therapy.
Mahanonda
N
N
Her Majesty The Queen's Cardiac Centre, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
D000818:Animals; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D015912:Thrombolytic Therapy; D014652:Vascular Diseases / Q000188:drug therapy*
D005343:Fibrinolytic Agents